Alexis V. Lukianov
Chairman of the Board and Chief Executive Officer
Alexis V. Lukianov is the Chairman of the Board and Chief Executive Officer of NuVasive®, Inc., a medical device company in San Diego, Calif. Since 1999, Mr. Lukianov has led a venture-backed startup to the company’s initial public offering in 2004. Today, NuVasive is the third largest spine company in the world and regarded as the leader in minimally disruptive surgical products having changed major spine surgery to outpatient procedures. The company’s innovative products and pioneering spine surgery techniques have catapulted the startup into an industry leader. Mr. Lukianov takes special pride in the company’s distinct performance culture that focuses on Speed of Innovation®- creating a sustainable competitive edge in the industry. Mr. Lukianov has over 30 years of experience in the orthopaedic industry, with nearly 25 years in senior management. Prior to joining NuVasive, he was a founder, and served as Chairman and Chief Executive Officer, of BackCare Group, Inc. Mr. Lukianov also held executive positions with Medtronic Sofamor Danek, including President of US. Additionally, he directed a business unit at Smith & Nephew Orthopaedics and managed an orthopaedic joint venture between Stryker Corporation and Meadox Medical. Mr. Lukianov attended Rutgers University and served in the U.S. Navy. Lukianov frequently participates on industry panels and in the media for patient advocacy and medical device industry topics.
Jack R. Blair
Jack R. Blair has served as a member of our Board of Directors since August 2001. During his 18-year career, Mr. Blair served in various capacities with Smith & Nephew PLC and Richards Medical Company, which was acquired by Smith & Nephew in 1986. Most recently, he was Group President of Smith & Nephew’s North and South American and Japanese operations (1986-1998) and held the position of President of Richards Medical Company (1982-1986). Until November 2007, when the company was sold, Mr. Blair served as Chairman of the Board of Directors of DJO Inc., an orthopaedic medical device company. He also serves as a director of a privately held orthopaedic company, a privately held tissue repair company, and a privately held specialty chemicals company. Mr. Blair holds a B.A. in Government from Miami University and an M.B.A. from the University of California, Los Angeles.
Lesley H. Howe
Lesley H. Howe has served as a member of our Board of Directors since February 2004. Mr. Howe has more than 40 years of experience in accounting, finance, and business management within a variety of industries. From December 2001 until May 2007, he served as Chief Executive Officer of Consumer Networks LLC, a San Diego-based Internet marketing and promotions company. During Mr. Howe’s 30-year career with KPMG Peat Marwick LLP, an international accounting and auditing firm, he was an audit partner for 23 years and an area managing partner/managing partner of the Los Angeles office of KPMG for three years. While there Mr. Howe worked as an independent financial and business consultant for three years, advising clients on acquisition due diligence and negotiation strategies, as well as financing strategies. Mr. Howe currently serves on the Board of Directors of Jamba Inc., the leading retailer of quality blended fruit beverages. Mr. Howe received a B.S. in Business Administration from the University of Arkansas.
Peter C. Farrell, Ph.D., AM
Peter C. Farrell, Ph.D., AM has served as a member of our Board of Directors since January 2005. Dr. Farrell was founding Chairman and Chief Executive Officer of ResMed, Inc., a leading developer and manufacturer of medical equipment for the diagnosis and treatment of sleep-disordered breathing. He held those positions from 1989 until 2007. Dr. Farrell holds bachelor’s and master’s degrees in Chemical Engineering from the University of Sydney and the Massachusetts Institute of Technology, a Ph.D. in Bioengineering from the University of Washington, Seattle, and a Doctor of Science from the University of New South Wales for research related to dialysis and renal medicine.
Ginger M. More
Ginger M. More has served as a member of our Board of Directors since June 2007. Ms. More was a General Partner at Oak Investments, one of the largest venture capital funds in the United States, for over 20 years. Ms. More founded Oak’s healthcare investment practice, and was also an active investor in information technology, with early stage investments in dozens of successful healthcare and technology companies. Her background includes leadership roles with Genzyme Corporation, Alexion Pharmaceuticals, OraPharma, Inc., Osteotech, Inc., and Compaq Computer. Ms. More retired from Oak in 2002, but continues to serve on several boards. She currently serves on the board of directors of KBL Healthcare Acquisition Corp. III, a publicly owned blank check corporation. Ms. More is Chairman Emeritus of the Connecticut Venture Group and a board member of the University of Connecticut Research and Development Corporation. She attended the University of Bridgeport and has achieved the Chartered Financial Analyst (CFA) designation.
Peter Leddy, Ph.D.
Peter Leddy, Ph.D., has served as a member of our Board of Directors since July 2011. Dr. Leddy’s success in driving business growth through the application of best-in-class, innovative Human Resource solutions has resulted in his leading several major employee and cultural transformation initiatives throughout his 25 year career. From 2005 to February 2014, Dr. Leddy served as Chief Human Resources Officer at Life Technologies, a biotechnology company. During his tenure at Life Technologies, Dr. Leddy developed a premier human resources function, aligning business strategy to business growth for 10,000 employees at over 80 sites worldwide. Prior to Life Technologies, Dr. Leddy held several senior management positions with Dell Incorporated, from 2000 to 2005, where he was responsible for leading global talent and human resources in the Americas, overseeing 7,500 employees. He has served as the Executive Vice President for Human Resources at Promus Hotel Corporation (Doubletree, Embassy Suites), implementing human resources strategies that drove operational excellence with 350 HR professionals in every level of the company. In addition, he has held a variety of executive and human resource positions at PepsiCo. Dr. Leddy currently serves on the board of directors of Pathway Genomics Corporation. He received his B.A. in Psychology from Creighton University and his M.S. and Ph.D. degrees in industrial/organizational psychology from the Illinois Institute of Technology.
Gregory T. Lucier
Gregory T. Lucier has served as a member of our Board of Directors since December 2013. From May 2003 to February 2014, Mr. Lucier served as the Chairman and Chief Executive Officer of Life Technologies (acquired by Thermo Fisher Scientific), a position he held since the merger of Invitrogen Corporation and Applied Biosystems in 2008. He served as Chief Executive Officer and President of Invitrogen from 2003 to 2008. Mr. Lucier is responsible for fostering a culture of excellence and applies his more than 25 years of strategic management at Life Technologies in his endeavor to shape an era of personalized medicine in which researchers can efficiently read, write and edit DNA for humanity’s benefit. Ranked 9th out of the 50 most innovative companies in the world and No. 1 in life sciences by Fast Company magazine, Life Technologies has a heritage of providing more than 50,000 leading products and services that enable breakthrough discoveries across the entire biological research spectrum. Mr. Lucier previously served as Chief Executive Officer and President at GE Medical Systems Information Technologies, Vice President for Global Services at GE Medical Systems and President of GE-Harris Railway Electronics. He received a bachelor’s degree in engineering from Pennsylvania State University and an MBA from Harvard Business School. He serves on the board of NuVasive, RainTree Oncology Services, Synthetic Genomics, Rady Children’s Hospital and is board chairman for Sanford Burnham Medical Research Institute.
Leslie V, Norwalk, Esq.
Leslie V Norwalk, Esq., has served as a member of our Board of Directors since May 2014. Ms. Norwalk serves as a Strategic Advisor and Strategic Counsel to Epstein Becker & Green, P.C., EBG Advisors, Inc., and National Health Advisors. Ms. Norwalk is an Operating Partner at Enhanced Equity Fund, L.P. She serves as an Advisor to Warburg Pincus LLC, and Ferrer Freeman & Company. Previously, Ms. Norwalk served the Bush Administration as the Acting Administrator for the Centers for Medicare & Medicaid Services, where she managed the day-to-day operations of Medicare, Medicaid, State Child Health Insurance Programs, Survey and Certification of health care facilities and other federal health care initiatives. For four years prior to that, she was the agency’s Deputy Administrator, responsible for the implementation of the changes made under the Medicare Modernization Act, including the Medicare Prescription Drug Benefit. Prior to serving the Bush Administration, Ms. Norwalk practiced law in the Washington, D.C. office of Epstein Becker & Green, P.C. where she advised clients on a variety of health policy matters. She also served in the first Bush administration in the White House Office of Presidential Personnel, and the Office of the U.S. Trade Representative. In addition to NuVasive, Ms. Norwalk serves as a Director of the following organizations: Primary Care Associates Medical Group, Inc., ikaSystems Corporation, Press Ganey Associates, and Abode Healthcare. Ms. Norwalk also serves as Member of International Advisory Council at APCO Worldwide Inc. She earned a J.D. degree from the George Mason University School of Law and a bachelor’s degree, cum laude, in Economics and International Relations from Wellesley College.